Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Nefopam Hydrochloride vs Acupan in Healthy Subjects
NCT03311022Phase 1Completed
- Sponsor
- Galen
- Start
- Nov 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of nefopam in pain (2 arms), sponsored by Galen. Primary endpoints: Maximum measurable plasma concentration and Area under the plasma concentration versus time curve from drug administration to last observed concentration. Started Nov 2015; status: completed.
02
Drugs
nefopam
03
Conditions
pain
Beyond the preview
Go deeper on NCT03311022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03311022.